In this study, we have identified the expression of SIRT2 in the hippocampus; treatment with Ad-SIRT2-GFP reversed the CUS-induced a reduction of depression-like behaviors and hippocampal neurogenesis. This evidence concerns the gene SIRT2 and depressive symptom measurement.